Abstract:Abstract Background The regeneration of bone loss that occurs after periodontal diseases is a significant challenge in clinical dentistry. Extracellular vesicles (EVs)-based cell-free regenerative therapies represent a promising alternative for traditional treatments. Developmental biology suggests matrix vesicles (MVs), a subtype of EVs, contain mineralizing-related biomolecules and play an important role in osteogenesis. Thus, we explore the therapeutic benefits and expect to find an optimized strategy for MV application. Methods Healthy human dental follicle cells (DFCs) were cultured with the osteogenic medium to generate MVs. Media MVs (MMVs) were isolated from culture supernatant, and collagenase-released MVs (CRMVs) were acquired from collagenase-digested cell suspension. We compared the biological features of the two MVs and investigated their induction of cell proliferation, migration, mineralization, and the modulation of osteogenic genes expression. Furthermore, we investigated the long-term regenerative capacity of MMVs and CRMVs in an alveolar bone defect rat model. Results We found that both DFC-derived MMVs and CRMVs effectively improved the proliferation, migration, and osteogenic differentiation of DFCs. Notably, CRMVs showed better bone regeneration capabilities. Compared to MMVs, CRMVs-induced DFCs exhibited increased synthesis of osteogenic marker proteins including ALP, OCN, OPN, and MMP-2. In the treatment of murine alveolar bone defects, CRMV-loaded collagen scaffold brought more significant therapeutic outcomes with less unhealing areas and more mature bone tissues in comparison with MMVs and acquired the effects resembling DFCs-based treatment. Furthermore, the western blotting results demonstrated the activation of the PLC/PKC/MAPK pathway in CRMVs-induced DFCs, while this cascade was inhibited by MMVs. Conclusions In summary, our findings revealed a novel cell-free regenerative therapy for repairing alveolar bone defects by specific MV subtypes and suggest that PLC/PKC/MAPK pathways contribute to MVs-mediated alveolar bone regeneration.

Matrix Vesicles as a Therapeutic Target for Vascular Calcification

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Role of matrix vesicles in bone-vascular cross-talk.

Exosomes, the Message Transporters in Vascular Calcification

Vascular calcification: Molecular mechanisms and therapeutic interventions

Vascular calcification: from the perspective of crosstalk

The role of mitochondria in vascular calcification

Role of endothelial cells in vascular calcification

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

A Narrative Review of Exosomes in Vascular Calcification

Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria

Cell-Matrix Interactions and Matricrine Signaling in the Pathogenesis of Vascular Calcification

Contributions of the Endothelium to Vascular Calcification

The Emerging Role of Mesenchymal Stem Cells in Vascular Calcification

Matrix Vesicle-Mediated Mineralization and Potential Applications

Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles

Vascular Calcification—New Insights into Its Mechanism

Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk

Endothelial-to-mesenchymal transition: New insights into vascular calcification

Extracellular vesicles in atherosclerosis and vascular calcification: the versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells

Matrix vesicles from dental follicle cells improve alveolar bone regeneration via activation of the PLC/PKC/MAPK pathway